Reader Request: Medical Marijuana Patches
One of our goals at www.MedicalMarijuanaEdu.com is to bring you, the patients and clinicians, educational information related to medical marijuana that you’re interested in learning more about. In this blog, we will address Medical Marijuana Patches, which has been one of the most asked about delivery mechanisms. As a reminder, please feel free to send us a message on our Contact page to ask questions and provide us with feedback.
Does it matter how you take medical marijuana?
As most of you know, the two most common forms to receive medical marijuana are 1) inhalation (e.g., a vaporizer) and 2) oral mucosal route (e.g., eaten in an edible or swallowed in a tincture). Both of these routes have benefits depending on your need. For example, when a quick-acting response is needed, inhalation is a preferred method since the onset of effect from the marijuana treatment is within 15min. However, the effects from inhalation usually subside quickly. For more chronic conditions, such as chronic pain or autoimmune issues, an oral route may be best due to the extended time of the effect, which can be 8hrs or more. A third route is now being introduced to the medical marijuana community in the form of Transdermal Patches.
Are transdermal patches the same as topicals?
No, most topicals are formulated to only penetrate the skin and deliver medicine locally to the site of application. Transdermal patches were developed to deliver the medicine through the skin and into the blood stream; thus, delivering medicine to the whole-body.
What should you look for in a transdermal patch?
The most important characteristic and quality to look for in a transdermal product is the “carrier” technology, which is usually labeled as an “inactive” ingredient. The medicinal compounds in marijuana are what scientists call lipophilic and are not water soluble. Because of this, manufacturers of transdermal patches need to use “carriers” to help move the marijuana molecules through the skin and into the bloodstream. The most common substance used is DMSO, which is a sulfate-based carrier. However, DMSO is a non-discriminate carrier that can carry contaminants into your blood stream along with the medication.
How is the MÜV transdermal patch different than other products?
The scientists at MÜV have been hard at work optimizing the technology to effectively and safely administer medical marijuana transdermally. They currently hold multiple patents for the “Evolve” encapsulation technology, which does not rely on the potentially harmful DMSO carrier method. This patent-pending patent pending encapsulation method to effectively increase the bioavailability of cannabinoids. In addition, MÜV products only use FDA GRAS inactive ingredients and are sourced from USP/NF, organic, and/or pharmaceutical grade manufacturers.
In addition, the MÜV transdermal patch is one of the only products that has been validated to transfer medical marijuana transdermally into the blood stream for the 72hr duration.